These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1135 related items for PubMed ID: 17714532

  • 21. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK, Kohli Y, Batra R.
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [Abstract] [Full Text] [Related]

  • 22. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
    Yenişehirli G, Tunçoğlu E, Yenişehirli A, Bulut Y.
    Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
    [Abstract] [Full Text] [Related]

  • 23. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L, Wang Z, Li R, Luo S, Sun X.
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
    Karaarslan A, Arikan S, Ozcan M, Ozcan KM.
    Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
    [Abstract] [Full Text] [Related]

  • 25. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA, Wraith LA, Cai B, Nyirady J, Isham N.
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile].
    Díaz Jarabrán MC, Díaz González P, Espinoza Rodríguez J, Carrillo Muñoz AJ.
    Rev Iberoam Micol; 2015 Sep; 32(2):83-7. PubMed ID: 24794211
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes.
    Ghannoum MA, Welshenbaugh A, Imamura Y, Isham N, Mallefet P, Yamaguchi H.
    Mycoses; 2010 Jul; 53(4):311-3. PubMed ID: 19422522
    [Abstract] [Full Text] [Related]

  • 28. Trichophyton species susceptibility to green and red propolis from Brazil.
    Siqueira AB, Gomes BS, Cambuim I, Maia R, Abreu S, Souza-Motta CM, de Queiroz LA, Porto AL.
    Lett Appl Microbiol; 2009 Jan; 48(1):90-6. PubMed ID: 19018958
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ, Giusiano G, Guarro J, Quindós G, Guardia C, del Valle O, Rodríguez V, Estivill D, Cárdenes CD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [Abstract] [Full Text] [Related]

  • 30. In vitro susceptibility of dermatophytes to oral antifungal drugs and amphotericin B in Uttar Pradesh, India.
    Singh SK, Patwa DK, Tilak R, Das A, Singh TB.
    Indian J Dermatol Venereol Leprol; 2019 Aug; 85(4):388-392. PubMed ID: 30950409
    [Abstract] [Full Text] [Related]

  • 31. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection.
    Ataides FS, Chaul MH, El Essal FE, Costa CR, Souza LK, Fernandes OF, Silva MR.
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum.
    Santos DA, Hamdan JS.
    J Clin Microbiol; 2005 Apr; 43(4):1917-20. PubMed ID: 15815018
    [Abstract] [Full Text] [Related]

  • 33. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
    Fernández-Torres B, Vázquez-Veiga H, Llovo X, Pereiro M, Guarro J.
    Chemotherapy; 2000 Apr; 46(6):390-4. PubMed ID: 11053904
    [Abstract] [Full Text] [Related]

  • 34. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    da Silva Barros ME, de Assis Santos D, Soares Hamdan J.
    Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
    [Abstract] [Full Text] [Related]

  • 35. What defines the quality of patient care in tinea pedis?
    Mistik S, Ferahbas A, Koc AN, Ayangil D, Ozturk A.
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):158-65. PubMed ID: 16441623
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
    Karaca N, Koç AN.
    Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
    [Abstract] [Full Text] [Related]

  • 37. Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
    Zhang J, Chen J, Huang HQ, Xi LY, Lai W, Xue RZ, Zhang XH, Chen RZ.
    Chin Med J (Engl); 2010 Jul; 123(14):1909-14. PubMed ID: 20819577
    [Abstract] [Full Text] [Related]

  • 38. [Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
    Solgun G, Fındık D, Türk Dağı H, Arslan U.
    Mikrobiyol Bul; 2011 Jan; 45(1):159-67. PubMed ID: 21341170
    [Abstract] [Full Text] [Related]

  • 39. In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller-Hinton Agar Plates.
    Intra J, Sarto C, Mazzola S, Fania C, Tiberti N, Brambilla P.
    Mycopathologia; 2019 Aug; 184(4):517-523. PubMed ID: 31297668
    [Abstract] [Full Text] [Related]

  • 40. Testing of antifungal combinations against yeasts and dermatophytes.
    Harman S, Ashbee HR, Evans EG.
    J Dermatolog Treat; 2004 Apr; 15(2):104-7. PubMed ID: 15204161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.